C12N 15/76
For actinomyces
Official title: for Actinomyces; for Streptomyces
C12N15/76 (For actinomyces) appears on 222 US grants and 126 published applications in this corpus.
Search patents in C12N- Granted patents
- 222
- Published applications
- 126
- Assignees
- 123
- Inventors
- 495
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 6 | 0 |
| 1983 | 3 | 0 |
| 1984 | 3 | 0 |
| 1985 | 6 | 0 |
| 1986 | 3 | 0 |
| 1987 | 8 | 0 |
| 1988 | 11 | 0 |
| 1989 | 8 | 0 |
| 1990 | 12 | 0 |
| 1991 | 5 | 0 |
| 1992 | 8 | 0 |
| 1993 | 14 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 9 | 0 |
| 1997 | 10 | 0 |
| 1998 | 7 | 0 |
| 1999 | 8 | 0 |
| 2000 | 5 | 0 |
| 2001 | 8 | 3 |
| 2002 | 2 | 7 |
| 2003 | 6 | 11 |
| 2004 | 6 | 7 |
| 2005 | 3 | 5 |
| 2006 | 5 | 2 |
| 2007 | 4 | 2 |
| 2008 | 3 | 4 |
| 2009 | 1 | 3 |
| 2010 | 2 | 2 |
| 2011 | 2 | 7 |
| 2012 | 2 | 2 |
| 2013 | 2 | 3 |
| 2014 | 1 | 4 |
| 2015 | 4 | 3 |
| 2016 | 1 | 4 |
| 2017 | 3 | 3 |
| 2018 | 0 | 1 |
| 2019 | 5 | 6 |
| 2020 | 2 | 5 |
| 2021 | 1 | 9 |
| 2022 | 6 | 7 |
| 2023 | 6 | 9 |
| 2024 | 4 | 6 |
| 2025 | 7 | 5 |
| 2026 | 0 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Phage-derived particles for in situ delivery of DNA payload into C. acnes population4 Nov 2025US 12,460,216 B2Eligo Bioscience
- Cutibacterium acnes recombinant phages encoding a human protein28 Oct 2025US 12,454,696 B2Eligo Bioscience
- Method for producing target protein14 Oct 2025US 12,442,007 B2Nagase Viita Co., Ltd.
- Serine proteases23 Sep 2025US 12,421,508 B2Danisco US Inc.
- Expression vector2 Sep 2025US 12,404,524 B2Terra Bioworks, Inc.
- New systems for producing recombinant proteins27 Aug 2026US 2026/0250693 A1Nemysis Limited
- Cutibacterium acnes recombinant phages, method of production and uses thereof6 Aug 2026US 2026/0226484 A1Eligo Bioscience
- Novel antibiotic compound23 Apr 2026US 2026/0109688 A1
- Method for the production of an enzymatic composition comprising a recombinant endopeptidase23 Apr 2026US 2026/0109962 A1Nemysis Limited
- Phage-derived particles for in situ delivery of dna payload into c. acnes population23 Apr 2026US 2026/0109991 A1Eligo Bioscience
Most cited
By later US patents
- Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants248US 5,561,236 ABiogen, Inc. · 1996
- Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants173US 7,112,665 B1Bayer BioScience N. V. · 2006
- Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants142US 5,646,024 APlant Genetic Systems, N.V. · 1997
- Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants127US 5,648,477 APlant Genetic Systems, N.V. · 1997
- Production of polyketides in bacteria and yeast88US 6,033,883 AKosan Biosciences, Inc. · 2000